| Oncogenic KRAS regulates tumor cell signaling via stromal reciprocation CJ Tape, S Ling, M Dimitriadi, KM McMahon, JD Worboys, HS Leong, ... Cell 165 (4), 910-920, 2016 | 408 | 2016 |
| The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models ST Durant, L Zheng, Y Wang, K Chen, L Zhang, T Zhang, Z Yang, ... Science advances 4 (6), eaat1719, 2018 | 235 | 2018 |
| AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity JHL Fok, A Ramos-Montoya, M Vazquez-Chantada, PWG Wijnhoven, ... Nature communications 10 (1), 5065, 2019 | 227 | 2019 |
| Pharmacology of the ATM inhibitor AZD0156: potentiation of irradiation and olaparib responses preclinically LC Riches, AG Trinidad, G Hughes, GN Jones, AM Hughes, ... Molecular cancer therapeutics 19 (1), 13-25, 2020 | 117 | 2020 |
| Universal sample preparation unlocking multimodal molecular tissue imaging A Dannhorn, E Kazanc, S Ling, C Nikula, E Karali, MP Serra, JL Vorng, ... Analytical Chemistry 92 (16), 11080-11088, 2020 | 66 | 2020 |
| Characterization of an aggregated three-dimensional cell culture model by multimodal mass spectrometry imaging LE Flint, G Hamm, JD Ready, S Ling, CJ Duckett, NA Cross, LM Cole, ... Analytical Chemistry 92 (18), 12538-12547, 2020 | 46 | 2020 |
| Method to visualize the intratumor distribution and impact of gemcitabine in pancreatic ductal adenocarcinoma by multimodal imaging N Strittmatter, FM Richards, AM Race, S Ling, D Sutton, A Nilsson, ... Analytical Chemistry 94 (3), 1795-1803, 2022 | 20 | 2022 |
| Transforming early pharmaceutical assessment of genotoxicity: applying statistical learning to a high throughput, multi end point in vitro micronucleus assay A Wilson, P Grabowski, J Elloway, S Ling, J Stott, A Doherty Scientific reports 11 (1), 2535, 2021 | 17 | 2021 |
| Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution N Strittmatter, JI Moss, AM Race, D Sutton, JR Canales, S Ling, E Wong, ... Theranostics 12 (5), 2162, 2022 | 10 | 2022 |
| Evaluation of UV-C decontamination of clinical tissue sections for spatially resolved analysis by mass spectrometry imaging (MSI) A Dannhorn, S Ling, S Powell, E McCall, G Maglennon, GN Jones, ... Analytical Chemistry 93 (5), 2767-2775, 2021 | 7 | 2021 |
| Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging N Strittmatter, P Kanvatirth, P Inglese, AM Race, A Nilsson, A Dannhorn, ... Journal of the American Society for Mass Spectrometry 32 (12), 2791-2802, 2021 | 6 | 2021 |
| Comparison of osteosarcoma aggregated tumour models with human tissue by multimodal mass spectrometry imaging LE Flint, G Hamm, JD Ready, S Ling, CJ Duckett, NA Cross, LM Cole, ... Metabolites 11 (8), 506, 2021 | 5 | 2021 |
| Method to investigate the distribution of water-soluble drug-delivery systems in fresh frozen tissues using imaging mass cytometry N Strittmatter, RM England, AM Race, D Sutton, JI Moss, G Maglennon, ... Analytical Chemistry 93 (8), 3742-3749, 2021 | 4 | 2021 |
| Intra-and intercellular signaling pathways associated with drug-induced cardiac pathophysiology F Guo, AR Hall, CJ Tape, S Ling, A Pointon Trends in pharmacological sciences 42 (8), 675-687, 2021 | 1 | 2021 |
| Efficacy and pharmacodynamic effect of anti-CD73/PD-L1 monoclonal antibodies in combination with chemotherapy: observations from mouse tumor models J Eyles, A Watkins, K Ilieva, S Mullins, J Anderton, E Galvani, F Garcon, ... Cancer Research 81 (13_Supplement), 1584-1584, 2021 | 1 | 2021 |
| Characterization of ATM inhibitor (AZD1390) distribution and pharmacodynamic changes in brain and glioblastoma in preclinical models to inform on mechanism of action L Oplustil O'Connor, G Hamm, M Udriste, S Ling, J Wilson, S Durant, ... Cancer Research 80 (16_Supplement), 6168-6168, 2020 | 1 | 2020 |
| Federation of Imaging Data for Life sciences: current status of metadata collection for high content screening, mass spectrometry imaging and light sheet microscopy of … F Brochu, E Cooke, M Romanchikova, J Bunch, A Dexter, R Steven, ... | 1 | 2020 |
| Acquisition and management of high content screening, light-sheet microscopy and mass spectrometry imaging data at AstraZeneca, GlaxoSmithKline and NPL: a survey report E Cooke, M Hayes, M Romanchikova, A Dexter, R Steven, S Thomas, ... | 1 | 2020 |
| Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function. EO Asowata, S Romoli, R Sargeant, JY Tan, S Hoffmann, MM Huang, ... Kidney International, 2024 | | 2024 |
| Metabolic imaging across scales reveals distinct prostate cancer phenotypes N Sushentsev, G Hamm, L Flint, D Birtles, A Zakirov, J Richings, S Ling, ... medRxiv, 2023.09. 29.23296228, 2023 | | 2023 |
Christopher TapeGroup Leader, University College London Cancer InstituteVerified email at ucl.ac.uk
